Severe bacterial infections in people who inject drugs: the role of injection-related tissue damage Full Text

‡ Two of 131 (1.53%) S.aureus infections were due to methicillin-resistant S.aureus (MRSA). The appropriateness of treatment was analyzed by at least two investigators, which were not informed about the outcome of the cases at time of analysis. Whenever a pathogen was isolated, antibiotic susceptibility testing was considered for treatment. Our laboratories are working according to Clinical and Laboratory Standards Institute (CLSI) guidelines.

Why should I care about antimicrobial resistance?

An evaluation of an ex-addict outreach program in Baltimore showed that IV drug users in the city were changing their behavior to reduce the risk of AIDS; however, the change could not be attributed to the efforts of the outreach workers (McAuliffe et al., 1987). In this sample, information and even perceived self-susceptibility were insufficient to alter behavior. The details of injection practices related to sharing, booting, rinsing, and heating the cooker vary greatly; in addition, these behaviors are constantly evolving in light of the awareness of the risk of HIV transmission. It is difficult to assess the impact of these behavioral changes on stemming the spread of HIV.

SAFER INJECTING PRACTICES

Drug users do not necessarily cooperate as research subjects by restricting their behavior to forms that can be studied using simple questionnaires. For example, single-substance drug use lends itself relatively easily to research design; the polydrug use that a significant portion of IV drug users actually report is much more difficult to measure (B. D. Johnson et al., 1985). To investigate these topics properly, old methodologies must be improved and new ones devised. Other studies reported in 1987 indicate some limitations on the AIDS prevention efforts aimed at IV drug users.

Availability of data and materials

Storage of cottons/filters and cookers already exposed to wet material could provide an environment for bacteria to remain viable and proliferate. The re-use of this drug injection equipment not only exposes the PWID to bacteria [45] but potentially a higher inoculum than other possible pathways for bacterial introduction. This study indicates the need for widespread provision of harm reduction supplies to PWID including clean injecting equipment and sterile water. There are now enough studies of AIDS risk reduction among IV drug users to derive some generalizations that describe the current state of knowledge. First, it is quite clear that IV drug users will modify their behavior to reduce their risk of AIDS. Although the studies that support this conclusion tend to rely heavily on self-reported behavioral modifications, there are enough studies in which there is some independent evidence of change to conclude that the self-reports reflect what has actually occurred.

• The list provides guidance on the development of new and necessary treatments to stop the spread of antimicrobial resistance (AMR).
• For these agencies, increases in the numbers justified calling for more public resources; decreases allowed policy makers to direct resources elsewhere.
• Only responses with paired pre- and postpresentation data from respondents who completed the entire training were included in the data analysis.
• Unfortunately, less is known about the rates of HIV infection among IV drug users than is known about the prevalence of AIDS.

Harm reduction – including needle/syringe programmes, opioid substitution therapy and community distribution of naloxone – is an evidence-based approach to HIV and HCV prevention, treatment and care for people who inject drugs. Harm reduction interventions are essential to achieve the global targets for viral hepatitis elimination and control of HIV/AIDS epidemics. This model was developed in response to providers’ reports of limited experience and comfort surrounding infection control strategies for reducing infections related to IDU [31].

Thus, reducing these risk factors and providing adequate medical care are important aims of opioid maintenance programs [10,11]. In general, IVDU seek medical treatment in emergency departments more often and also need to be hospitalized more often than patients in an age-matched non-IVDU population [4,10]. The resulting delay in diagnosis and possibly reduced number of available therapeutic options may produce a less favorable outcome to treatment as well as more frequent and potentially life-threatening complications. Practice guidelines for uncomplicated skin abscesses following incision and drainage recommend antibiotic therapy to decrease the risk of infection [49].

• In health care, antibiotics are one of our most powerful drugs for fighting life-threatening bacterial infections.
• The tool was presented during existing educational forums, such as grand rounds or resident conferences.
• Water is used to rinse out syringes and needles before they are reused—not necessarily to decontaminate the equipment but to prevent clotting and therefore unusable works.
• Ethnographic research may be the more appropriate method of obtaining critical information about such topics as the dynamics of IV drug use, including the initiation and continuation of drug-use behaviors (Waldorf, 1980).
• Therefore, there may be a perception among health care workers that IVDU will be less willing to consent to or follow a specific antibiotic therapy.

The most commonly reported means taken to avoid HIV infection were the increased use of illicit sterile injection equipment, reduction in the number of persons with whom the respondent was willing to share equipment, and reduction or cessation of IV drug use. The use of nonsterile injection equipment may account for a range of infections in IV drug users, including bacterial endocarditis, hepatitis, malaria, and cellulitis or soft tissue infections (Louria et al., 1967). As the number of people with whom iv drug use injection equipment is shared increases, so does the risk of HIV infection (Chaisson et al., 1987b). As with other blood-borne infections to which IV drug users are prone, HIV spreads from the infected to the uninfected user primarily by the sharing of blood-contaminated injection equipment, which serves as the vector of the virus. On average, at least one person with a bacterial or fungal infection who also injects drugs visited one of the five assessed hospitals every day during the analysis period.

Substance Use Disorder, Intravenous Injection, and HIV Infection: A